AI infrastructure and strong earnings drive market attention today. E2E Networks secures a ₹1,000 crore NVIDIA GPU deal, while Milky Mist Dairy’s Q1 profit surges 890%. Cipla also gains focus with a strategic oncology licensing pact.

Cipla

• Deal: Signs exclusive licensing agreement with SBP Group for HER2 bispecific ADC TQB2102, covering India, South Africa, and five emerging markets. Stock closed at ₹1409.20 in the previous session, down 1.00%.
• Regulatory: USFDA classifies InvaGen Unit 3 inspection as Voluntary Action Indicated, indicating compliant standing with no immediate regulatory action recommended.
• Corporate action: JV Aspergen Ltd acquires 100% stake in Aspergen Inc. USA to rationalise group structure, with economic interest remaining unchanged.

Titan Biotech

• Corporate action: Board meeting scheduled for September 3 to consider bonus share issuance and finalize FY26 reports. Stock closed at ₹380.00 in the previous session, down 0.67%.

Indo Tech Transformers

• Order Book: Wins ₹54 crore work order from Waaree Renewable Technologies for five power transformers, breaking a period of no reported inflows. Stock closed at ₹3703.30 in the previous session, down 1.43%.
• Corporate action: Files FY26 annual report recommending a ₹10 per share final dividend and seeking approval to increase borrowing powers to ₹500 crore.

E2E Networks

• Order Book: Secures ₹1,000 crore order from a sovereign AI firm for supply of NVIDIA Blackwell cloud GPUs, highlighting rising AI compute demand. Stock closed at ₹618.75 in the previous session, up 0.38%.
• Fund raise: Board approves fundraise of up to ₹1,500 crore via equity or other securities, with AGM scheduled for September 28.

Time Technoplast

• Earnings: FY26 consolidated PAT rises 20.8% YoY to ₹4,766.14 crore on volume growth of 13.5% and margin expansion to 14.7%. Stock closed at ₹187.19 in the previous session, up 0.48%.
• Sustainability: Plans ₹120 crore investment in recycling facilities and targets sourcing 75% of power from green energy within two years.
• Order Book: Secures new order worth ₹87.53 crore, reflecting continued business development activity.

Brigade Enterprises

• Deal: Enters Coimbatore market with ₹600 crore residential Joint Development Agreement project in Saravanampatti, expanding South India footprint. Stock closed at ₹655.85 in the previous session, up 2.12%.

NCC

• Order Book: Wins ₹430.19 crore confirmed work orders for Buildings Division, adding to total disclosed book of ₹8,150.26 crore. Stock closed at ₹148.37 in the previous session, flat 0.02%.
• Corporate action: Shareholders approve ₹2.20 per share dividend and reappoint directors at 36th AGM held on August 27.

Midwest

• Deal: Accepts Letters of Intent from APMDC for granite quarry leases in Andhra Pradesh, securing mineral resource rights. Stock closed at ₹1096.80 in the previous session, down 0.89%.

Milky Mist Dairy Food

• Earnings: Q1FY27 net profit surges 890% YoY to ₹64.68 crore on 43.6% revenue growth driven by 153% jump in yogurt sales. Stock closed at ₹210.94 in the previous session, down 1.57%.
• Corporate action: Board approves alteration of Articles of Association following termination of Shareholders' Agreement with investors.

NLC India

• Deal: Forms JV with NCRTC for 110 MW solar project in Uttar Pradesh, holding 74% equity with 25-year captive PPA. Stock closed at ₹267.40 in the previous session, down 1.18%.
• Regulatory: Receives Telangana LOI for two mineral blocks containing vanadium and titanium; fined ₹14.31 lakh each by BSE/NSE for board compliance lapses.

Tilaknagar Industries

• Guidance: Targets double-digit volume growth in FY27 and plans sixfold expansion in Prag production capacity. Stock closed at ₹561.05 in the previous session, down 1.08%.
• Deal: Chairman signals openness to another large deal after Imperial Blue buyout, focusing on craft spirits in super premium segments.

Bottom Line

The day is defined by aggressive capex in AI infrastructure and robust earnings from consumer staples. While E2E Networks and Milky Mist drive positive sentiment with large orders and profit surges, broader market caution keeps mid-caps like Cipla and NCC under pressure despite solid operational news.